Edit company profile
No company profile.
Submit
Picture
Ginkgo Bioworks, which is building the leading platform for cell programming and biosecurity, and Syngenta Seeds, one of the world's leading agricultural techno...
Solvay, a leading science and materials company whose technologies bring benefits to many aspects of daily life, announced a strategic collaboration with Ginkgo...
Zymtronix and Ginkgo Bioworks announced a partnership to optimize enzymes used in Zymtronix's proprietary cell-free platform for the production of important ing...
Bayer announced that the company has closed the previously announced transaction with Ginkgo Bioworks to begin a multi-year strategic partnership to accelerate ...
Ginkgo Bioworks and the biotechnology company Zymergen announced they have entered into a definitive agreement under which Ginkgo will acquire Zymergen in an al...
Ginkgo Bioworks, the leading horizontal platform for cell programming, announced the signing of a definitive agreement for the previously announced transaction ...
Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, has published its inaugural Sustainability Report.
Bayer has announced that the company is pursuing an agreement whereby Ginkgo Bioworks will acquire Bayer’s West Sacramento Biologics Research & Development (R&...
Twist Bioscience Corporation and Ginkgo Bioworks have announced a new supply agreement expanding the depth and breadth of the collaboration between two of the l...
Joyn Bio is engineering plant microbes to develop high- performing biologicals to help growers overcome challenges and offer new agricultural solutions.
Ginkgo Bioworks, Inc. announced the signing of a program in a partnership with the Sumitomo Chemical Co., Ltd. Sumitomo Chemical seeks to leverage Ginkgo's long...
Corteva Agriscience LLC and Ginkgo Bioworks, Inc. announced that they have entered into a multi-year agreement to apply the power of synthetic biology to design...
Ginkgo Bioworks, the organism company and Berkeley Lights, Inc., a company dedicated to finding the best cells, recently announced a $150MM collaboration. Throu...
Ginkgo Bioworks, the organism company, announced a Series E financing round of $290 million with participation from all existing major investors and other new i...
Ginkgo Bioworks announced the opening of Bioworks4, its latest biological engineering foundry. With this fourth foundry, Ginkgo expands its footprint to nearly ...
Bayer and Ginkgo Bioworks announced the official name of its joint venture, Joyn Bio.Bayer and Ginkgo founded Joyn Bio in September 2017 and have since establis...
Ginkgo Bioworks, the organism company, today announced the opening of Bioworks3 – Ginkgo's third foundry for prototyping and scaling engineered organisms. This...